Collagénik
Natural health product licensed in Canada
- Licence holder
- Laboratoires OXUS inc.
- NPN or DIN-HM
- 80034994
- Status
- Active licence
- Licence date
- 27 August 2012
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Collagène hydrolysé Source : Poisson (Os) Potency : 3 % L-Lysine | 400 mg | Not calculated |
| Collagène hydrolysé Source : Poissons -Peau Potency : 3 % L-Lysine | 400 mg | Not calculated |
| Cervus elaphus Source : Ramure Potency : 3 % L-Lysine | 62.5 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 3 Tous les jours |
Uses authorised in Canada
Aide au développement et au maintien des os, du cartilage, des dents et des gencives. Aide au maintien et à la formation du tissu conjonctif. Favorise la cicatrisation des blessures.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consultez un praticien de soins de santé avant utilisation si vous suivez un régime faible en protéines. Consultez un praticien de soins de santé avant utilisation si vous êtes enceinte ou si vous allaitez.
- Effets indésirables connus
Peut provoquer un léger inconfort gastro-intestinal. Peut provoquer des symptômes d¿allergie chez les personnes sensibles. Cessez l¿utilisation et consultez un praticien de soins de santé si tel est le cas.
Source
Official Health Canada record, licence 80034994
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.